Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group.
about
Bisphosphonates for advanced prostate cancerBisphosphonates for the relief of pain secondary to bone metastases.Increased degradation of type I collagen in patients with inflammatory bowel disease.Clodronate in the prevention and treatment of skeletal metastasis.Type I and type III collagen metabolites in adult osteosarcoma patientsMarkers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma.Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancerMarkers of bone turnover for the management of patients with bone metastases from prostate cancerAssessing pharmacological interventions for bone metastases: the need for more patient-centered outcomes.Clodronate and other bisphosphonates as supportive therapy in osteolysis due to malignancy.Bisphosphonates for advanced prostate cancer.Possible bone-preserving capacity of high-dose intramuscular depot estrogen as compared to orchidectomy in the treatment of patients with prostatic carcinoma.Biochemical markers of bone turnover in breast cancer patients with bone metastases: a preliminary report.
P2860
Q24244161-838E8901-9913-4CF5-93FA-E85C313EAA47Q32139406-B62C7ECA-0C53-46E4-B1A9-9D28B3190D55Q34409296-BC2AD2CC-7B53-4EB4-B54A-E3220DCC6BDBQ36118379-6027EF97-4B48-4B34-8EA9-40AC1B41D76AQ36134368-8C0DA879-B9CD-425D-BF5F-0FAEA6FFE374Q36134836-CB34CB37-6336-49D6-A53C-6ADECE560CF6Q36431182-37F1B5E0-5F9E-4E97-8FFE-7E24FA910330Q36641310-96ADB4CB-31AC-4D08-AEC8-2642573A1E07Q38018675-7F2E0271-BCA4-4028-B618-E2EFA9E3F12EQ40405369-F907DAC4-96EB-49FE-98B5-6D8DD8123124Q47248454-396F1843-CB27-48B3-98AB-6EED074BD21EQ50953817-4D76B815-9396-4650-A746-5C7DBE95D4CFQ51564833-75CE53E4-A6C4-43F3-952C-71879FABED4E
P2860
Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Evaluation of the effect of or ...... Finnish Prostate Cancer Group.
@en
Evaluation of the effect of or ...... Finnish Prostate Cancer Group.
@nl
type
label
Evaluation of the effect of or ...... Finnish Prostate Cancer Group.
@en
Evaluation of the effect of or ...... Finnish Prostate Cancer Group.
@nl
prefLabel
Evaluation of the effect of or ...... Finnish Prostate Cancer Group.
@en
Evaluation of the effect of or ...... Finnish Prostate Cancer Group.
@nl
P2093
P1476
Evaluation of the effect of or ...... Finnish Prostate Cancer Group.
@en
P2093
P304
P356
10.1016/S0959-8049(05)80417-4
P577
1993-01-01T00:00:00Z